Evidence map›Paper›PMID 27435339›Full record

ArticlePhysics in medicine and biology2016

Dose enhancement effects to the nucleus and mitochondria from gold nanoparticles in the cytosol.

A L McNamara, W W Y Kam, N Scales, S J McMahon, J W Bennett, H L Byrne, J Schuemann, H Paganetti, R Banati, Z Kuncic

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. In Vitro Methods for Assessing Nanoparticle Toxicity.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  14. Article
  15. Article
  16. Metal-basedTheranostics · 2018
    Review
  17. Article
  18. Article
  19. Validation of the radiobiology toolkit TOPAS-nBio in simple DNA geometries.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · 2017
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

A L McNamaraDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 30 Fruit St, Boston, MA 02114, USA.
W W Y KamAustralian Nuclear Science and Technology Organisation, Lucas Heights, NSW 2234, Australia.
N ScalesAustralian Nuclear Science and Technology Organisation, Lucas Heights, NSW 2234, Australia.
S J McMahonDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 30 Fruit St, Boston, MA 02114, USA.
J W BennettAustralian Nuclear Science and Technology Organisation, Lucas Heights, NSW 2234, Australia.
H L ByrneSchool of Physics, University of Sydney, NSW 2006, Australia.
J SchuemannDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 30 Fruit St, Boston, MA 02114, USA.
H PaganettiDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 30 Fruit St, Boston, MA 02114, USA.
R BanatiAustralian Nuclear Science and Technology Organisation, Lucas Heights, NSW 2234, Australia.
Z KuncicSchool of Physics, University of Sydney, NSW 2006, Australia.
Australian Nuclear Science and Technology Organisation · AUMassachusetts General Hospital · USUniversity of Sydney · AUHarvard University · US

Funding

TOPAS - nBio, a Monte Carlo tool for radiation biology researchR01CA187003 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SCHUEMANN, JAN PATRICK OSCAR · 2015 to 2024
$4.8M
NCI NIH HHS R01 CA187003
6 · The paper itself

Abstract

Gold nanoparticles (GNPs) have shown potential as dose enhancers for radiation therapy. Since damage to the genome affects the viability of a cell, it is generally assumed that GNPs have to localise within the cell nucleus. In practice, however, GNPs tend to localise in the cytoplasm yet still appear to have a dose enhancing effect on the cell. Whether this effect can be attributed to stress-induced biological mechanisms or to physical damage to extra-nuclear cellular targets is still unclear. There is however growing evidence to suggest that the cellular response to radiation can also be influenced by indirect processes induced when the nucleus is not directly targeted by radiation. The mitochondrion in particular may be an effective extra-nuclear radiation target given its many important functional roles in the cell. To more accurately predict the physical effect of radiation within different cell organelles, we measured the full chemical composition of a whole human lymphocytic JURKAT cell as well as two separate organelles; the cell nucleus and the mitochondrion. The experimental measurements found that all three biological materials had similar ionisation energies  ∼70 eV, substantially lower than that of liquid water  ∼78 eV. Monte Carlo simulations for 10-50 keV incident photons showed higher energy deposition and ionisation numbers in the cell and organelle materials compared to liquid water. Adding a 1% mass fraction of gold to each material increased the energy deposition by a factor of  ∼1.8 when averaged over all incident photon energies. Simulations of a realistic compartmentalised cell show that the presence of gold in the cytosol increases the energy deposition in the mitochondrial volume more than within the nuclear volume. We find this is due to sub-micron delocalisation of energy by photoelectrons, making the mitochondria a potentially viable indirect radiation target for GNPs that localise to the cytosol.

Indexed as

PhotonsCell NucleusCytosolGoldHumansJurkat CellsMetal NanoparticlesMitochondriaMonte Carlo MethodRadiation DosageGold

Identifiers

PMID27435339
PMCPMC4993038
OpenAlexW2495835442

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.